• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA SP WITH MAXZERO; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383556
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Codes Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/13/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3.The date received by manufacturer has been used for this field.H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
It was reported that bd nexiva sp with maxzero leaked from the septum.The following information was provided by the initial reporter: i received this information from xxx in and email and the attached picture was sent also.We have had two of this product leak in the last 2 days.
 
Additional Manufacturer Narrative
Additional information/correction.Describe event or problem.Annex e and f codes updated.
 
Event or Problem Description
Additional information 07/07/2025.1.Was there any harm/serious injury to the patient directly related to the reported event? no harm done to the patients.2.Please confirm the number of different patients implicated in this reported event.3 patients.
 
Additional Manufacturer Narrative
The complaint of a leak at the septum was confirmed from the photograph that was provided for investigation.The photo showed what appeared to be blood residue on the external surface of the canister, which indicates that blood bypassed the septum.No damage or defects were observed on the unused 20g nexiva units that were provided for investigation from lot #5058238.A visual examination and functional test of the physical samples revealed no leaks in the device.The septum on each physical sample was sitting in its proper location within the catheter adapter.The appropriate manufacturing personnel were notified of this complaint.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No new information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA SP WITH MAXZERO
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key22411136
Report Number1710034-2025-01135
Device Sequence Number8293599
Product Code FOZ
UDI-Device Identifier00382903835560
UDI-Public(01)00382903835560(11)250227(17)280229(10)5058238
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383556
Device Lot Number5058238
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/13/2025
Supplement Date Received by ManufacturerNot provided
08/12/2025
Initial Report FDA Received Date07/07/2025
Supplement Report FDA Received Date07/14/2025
08/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/27/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-